Kieran Mudryy - Profile and Investment Details

Investor Profile

Kieran Mudryy is a Venture Capital, Private Equity Firm, Investor based in Singapore, Central Singapore Community Development Council, Singapore with a diverse investment portfolio that includes companies such as Redpin Therapeutics, Detego, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics, Cellectis, SparingVision, UltraSoc, Cambridge Nanotherm Ltd, Carisma Therapeutics, Picodeon Ltd Oy, Araris Biotech, Autolus, . Over time, Kieran Mudryy has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kieran Mudryy is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Genetics, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Finance, Biotechnology, Genomics, Productivity Software, Reviews and Recommendations, Gene Therapy, Personalized Medicine, Health Diagnostics, UK-based Startups, Medical, B2B, Therapeutics, Cellular Therapy, Media and Entertainment, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Kieran Mudryy, as their portfolio suggests a familiarity and interest in this area.

Understanding Kieran Mudryy’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.